source
- AstraZeneca and Alexion receive FDA nod for Klygefa, a weekly self-administered myasthenia gravis therapyAstraZeneca and Alexion announced that the U.S. Food and Drug Administration approved their joint drug Klygefa (gefurulimab) on Monday. Klygefa is a self-administered biologic designed for patient…
- Expert warns that newer obesity GLP-1 drugs could spark access battles in low-income nationsLower‑cost generic versions of semaglutide, sold as Wegovy for obesity, have begun appearing in several markets and are expected to reach more countries soon. At the same time, pharmaceutical compa…